In the company's second-quarter results call, Lilly's chief scientific officer Daniel Skovronsky revealed that orally active anti-tau drug LY3372689 – an O-GlcNAcase (OGA) inhibitor – failed a ...

After 24 weeks, those proportions reached 74.1% and 64.9% respectively, with the tolerability profile of the drug consistent with the phase 2 FRONTIER 1 and 2 studies reported last year.

Robert Downey Jr. has evolved into one of the most respected actors in Hollywood. With an amazing list of credits to his name, he has managed to stay new and fresh even after over four decades in the ...